We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers

    Background

    Combining PARP inhibitors (PARPis) with immune checkpoint inhibitors may improve clinical outcomes in selected cancers. We evaluated...

    Rebecca Kristeleit, Alexandra Leary, ... Linda Mileshkin in British Journal of Cancer
    Article Open access 06 July 2024
  2. Exploring the causal association between uric acid and lung cancer in east Asian and European populations: a mendelian randomization study

    Background

    Lung cancer still ranks first in the mortality rate of cancer. Uric acid is a product of purine metabolism in humans. Its presence in the...

    ** Lin, Linxiang Zhang, ... Jihuang Wang in BMC Cancer
    Article Open access 05 July 2024
  3. A streamlined method to generate endothelial cells from human pluripotent stem cells via transient doxycycline-inducible ETV2 activation

    The development of reliable methods for producing functional endothelial cells (ECs) is crucial for progress in vascular biology and regenerative...

    Allen Chilun Luo, Jiuhai Wang, ... Juan M. Melero-Martin in Angiogenesis
    Article 05 July 2024
  4. Participants’ perspectives of being recruited into a randomised trial of a weight loss intervention before colorectal cancer surgery: a qualitative interview study

    Background

    The period between cancer diagnosis and surgery presents an opportunity for trials to assess the feasibility of behaviour change...

    Amelia Talbot, Susan A Jebb, ... Dimitrios A Koutoukidis in BMC Cancer
    Article Open access 05 July 2024
  5. Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series

    Over the last decades, the therapeutic armamentarium of metastatic renal cell carcinoma (mRCC) has been revolutionized by the advent of...

    Mimma Rizzo, Gaetano Pezzicoli, ... Silvana Quaglini in BMC Cancer
    Article Open access 05 July 2024
  6. Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years

    Autologous(auto-) and allogeneic(allo-) hematopoietic stem cell transplantation (HSCT) are key treatments for relapsed/refractory diffuse large...

    Philipp Berning, Mathilde Fekom, ... Norbert Schmitz in Blood Cancer Journal
    Article Open access 05 July 2024
  7. HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer

    Background

    Resistance to chemotherapy is a major problem in the treatment of patients with triple-negative breast cancer (TNBC). Preclinical data...

    Andrej Besse, Lenka Sedlarikova, ... Lenka Besse in British Journal of Cancer
    Article Open access 05 July 2024
  8. Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma

    Background

    Recent studies have highlighted the significant role of the NF-κB signaling pathway in the initiation and progression of cancer....

    Feng **ao, Hong Zhu, ... Hua Guo in Journal of Experimental & Clinical Cancer Research
    Article Open access 05 July 2024
  9. lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1

    Background

    The vast majority of lncRNAs have low expression abundance, which greatly limits their functional range and impact. As a high expression...

    Shanshan Qin, Yue Liu, ... Dandan Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 05 July 2024
  10. Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy

    Background

    The outcome of hepatocellular carcinoma (HCC) is limited by its complex molecular characteristics and changeable tumor microenvironment...

    Bufu Tang, **yu Zhu, ... Jiansong Ji in Molecular Cancer
    Article Open access 05 July 2024
  11. Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients

    Background

    The BCR::ABL1 is a hallmark of chronic myeloid leukemia (CML) and is also found in acute lymphoblastic leukemia (ALL). Most genomic breaks...

    Lenka Hovorkova, Lucie Winkowska, ... Jan Zuna in Molecular Cancer
    Article Open access 05 July 2024
  12. Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study

    Background

    Trabectedin in combination with pegylated liposomal doxorubicin (PLD) is approved for the treatment of patients with platinum-sensitive...

    María Jesús Rubio, Aránzazu Manzano, ... Antonio González-Martín in BMC Cancer
    Article Open access 05 July 2024
  13. NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

    Background

    Radioresistance is the leading cause of death in advanced cervical cancer (CC). Dysregulation of RNA modification has recently emerged as a...

    Min Yu, Mengdong Ni, ... Guihao Ke in Molecular Cancer
    Article Open access 05 July 2024
  14. Cancer cell extravasation requires iplectin-mediated delivery of MT1-MMP at invadopodia

    Background

    Invadopodia facilitate cancer cell extravasation, but the molecular mechanism whereby invadopodia-specific proteases such as MT1-MMP are...

    Olivia R. Grafinger, John J. Hayward, ... Hon S. Leong in British Journal of Cancer
    Article 05 July 2024
  15. Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition

    Arteriovenous malformations (AVM) are benign vascular anomalies prone to pain, bleeding, and progressive growth. AVM are mainly caused by mosaic...

    Friedrich G. Kapp, Farhad Bazgir, ... Jochen Rössler in Angiogenesis
    Article Open access 05 July 2024
  16. Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

    Anticancer systemic therapy comprises a complex and growing group of drugs. Some of the new agents with novel mechanisms of action that have appeared...

    Lorena Ostios-Garcia, Daniel Martínez Pérez, ... Enrique Espinosa in Cancer and Metastasis Reviews
    Article Open access 05 July 2024
  17. Metabolic adaptations in prostate cancer

    Prostate cancer is one of the most commonly diagnosed cancers in men and is a major cause of cancer-related deaths worldwide. Among the molecular...

    Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo in British Journal of Cancer
    Article Open access 05 July 2024
  18. Differentiation of glioma and solitary brain metastasis: a multi-parameter magnetic resonance imaging study using histogram analysis

    Background

    Differentiation of glioma and solitary brain metastasis (SBM), which requires biopsy or multi-disciplinary diagnosis, remains sophisticated...

    Yifei Su, Rui Cheng, ... Cheng Xu in BMC Cancer
    Article Open access 05 July 2024
Did you find what you were looking for? Share feedback.